0.6500
-0.0100
(-1.52%)
At close: January 31 at 7:59:54 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
Operating Cash Flow
-682.0000
-682.0000
-468.0000
Investing Cash Flow
--
--
8.0000
Financing Cash Flow
715.0000
715.0000
401.0000
End Cash Position
60.0000
60.0000
34.0000
Issuance of Capital Stock
392.0000
392.0000
--
Issuance of Debt
323.0000
323.0000
401.0000
Free Cash Flow
-682.0000
-682.0000
-468.0000
12/31/2022 - 8/11/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VX1.HM Vertex Pharmaceuticals Inc
447.95
+6.10%
22UA.F BioNTech SE
119.90
+0.84%
22UA.DE BioNTech SE
118.40
-0.17%
RNXT RenovoRx, Inc.
1.3600
+2.26%
DTIL Precision BioSciences, Inc.
5.01
-3.84%
AMLX Amylyx Pharmaceuticals, Inc.
3.6500
+3.99%
CGTX Cognition Therapeutics, Inc.
0.7230
-5.90%
CVAC CureVac N.V.
3.7900
-0.79%
REVB Revelation Biosciences, Inc.
3.7700
-1.31%
EYEN Eyenovia, Inc.
0.0346
-0.86%